Free Access
Med Sci (Paris)
Volume 33, Number 5, Mai 2017
Page(s) 549 - 554
Section Forum
Published online 14 June 2017
  1. Jordan B. Les débuts de CRISPR en thérapie génique. Med Sci (Paris) 2016 ; 32 : 1035–1037. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Ledford H. Broad Institute wins bitter battle over CRISPR patents. Nature 2017 ; 542 : 401. [CrossRef] [PubMed] [Google Scholar]
  3. Liang P, Xu Y, Zhang X, et al. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 2015 ; 6 : 363–372. [CrossRef] [PubMed] [Google Scholar]
  4. Kang X, He W, Huang Y, et al. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing. J Assist Reprod Genet 2016 ; 33 : 581–588. [CrossRef] [PubMed] [Google Scholar]
  5. Tang L, Zeng Y, Du H, et al. CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein. Mol Genet Genomics 2017 Mar 1. doi: 10.1007/s00438-017-1299-z. [Google Scholar]
  6. Hohmann S. Editor’s comment on “CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein”. Mol Genet Genomics. 2017 ; Mar 1. doi: 10.1007/s00438-017-1300-x [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.